SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

OpenAI raises $110 billion at $730 billion valuation in landmark AI funding round

U.S. authorizes departure of Embassy staff in Israel amid rising Iran tensions

Pentagon embraces Musk’s Grok while pressuring Anthropic to loosen AI safeguards

Israel’s cyber front intensifies as attack attempts and alerts soar

Buzz

Most popular

Daily

Weekly

1

Koi sold to Palo Alto for $400 million before most employees received options

2

Wiz throws a $3 million party as its $32 billion Google deal nears the finish line

3

Claude Code Security didn’t kill cybersecurity. It exposed what’s coming next.

4

Secretive Israeli cyber startup Glow raising over $100 million at $1 billion-plus valuation without a public product

5

Three founders raise $6 million to build a company with no employees

Arkin

2 stories about Arkin

Arkin raises $100 million biotech fund focused on early clinical science

Arkin Bio Ventures III emphasizes scientific rigor amid shifting biotech markets.

Censa Pharmaceuticals Signs Joint Development Agreement with Biotech Company Retrophin

07.01.18|Lilach Baumer

Censa, a company developing treatments for orphan metabolic diseases, is a portfolio company of Israel-based Arkin Bio Ventures